Floatz logo

Lipitor

Primary Biliary Cirrhosis

Medical University of GrazPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Primary Biliary Cirrhosis cohort.

Asset / SponsorPhaseRating
URSODEOXYCHOLIC ACID
Xijing Hospital of Digestive Diseases
Phase 4A
Saroglitazar
Zydus Therapeutics Inc.
Phase 3BB
Fenofibrate
Xijing Hospital of Digestive Diseases
Phase 3BB
cs0159
Cascade Pharmaceuticals, Inc
Phase 3BB
Obeticholic Acid
Intercept Pharmaceuticals
Phase 3BB

View all 50 →

Same molecule, other indications

Lipitor is also rated in:

inherited lipid metabolism disorderDormant
A
Indicative ·
83 / 100
View asset →
hyperlipidemiaDormant
BBB
Indicative ·
79 / 100
View asset →
HypercholesterolemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →